Search Within

David P Kelsen

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (64)
  2. Journal Article (62)
Groups
  1. Biostatistics Service (126)
  2. Center for Pancreatic Cancer Research (126)
  3. Department of Medicine (126)
  4. Epidemiology and Biostatistics (126)
  5. Gastrointestinal Oncology Service (126)
  6. Solid Tumor Oncology Division (126)

More Groups

People
  1. Marinela Capanu (98)
  2. David Ilson (53)
  3. Manish Shah (48)
  4. Eileen O'Reilly (47)
  5. Yelena Janjigian (44)
  6. Joanne Chou (41)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (3)
  5. 2020 (8)
  6. 2019 (12)

More Years

Publications
  1. Journal of Clinical Oncology (67)
  2. Cancer (11)
  3. Clinical Cancer Research (9)
  4. Annals of Oncology (6)
  5. American Journal of Clinical Oncology (3)
  6. Annals of Surgical Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (67)
  2. American Association for Cancer Research (12)
  3. Wiley Blackwell (12)
  4. Oxford University Press (9)
  5. Springer (7)
  6. Nature Publishing Group (4)

More Publishers

Results (126)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of Pembrolizumab and OLApaRib (POLAR) maintenance for select patients (pts) with metastatic pancreatic cancer (mPC) with (A) homologous recombination deficiency (HRD), (B) non-core HRD (ncHRD) and (C) exceptional response to platinum
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J.; Schwartz, C.; Larsen, M.; Varghese, A.; Yu, K.; Balogun, F.; Yang, J.; Katz, S.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of patients with metastatic colitis-associated cancer treated with EGFR inhibitors
    Meeting Abstract

    Yeh, C.; Cowley, C.; Srivastava, A.; Chatila, W. K.; Ismailgeci, D.; Chou, J. F.; Capanu, M.; Shah, M. A.; Sanchez-Vega, F.; Ganesh, K.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC)
    Meeting Abstract

    Keane, F.; Saadat, L.; O'Connor, C.; Chou, J. F.; Brannon, A. R.; Cowzer, D.; Crowley, F.; Debnath, N.; Bowman, A.; Xu, F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Phase 2 trial of pembrolizumab and olaparib (POLAR) maintenance for patients (pts) with metastatic pancreatic cancer (mPDAC): Two cohorts B non-core homologous recombination deficiency (HRD) and C exceptional response to platinum-therapy
    Meeting Abstract

    Park, W.; O'Connor, C.; Chou, J. F.; Schwartz, C.; Varghese, A. M.; Larsen, M.; Balogun, F.; Brenner, R.; Yu, K. H.; Diguglielmo, E.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Perioperative versus total neoadjuvant chemotherapy in gastric cancer
    Journal Article

    Yang, J.; Greally, M.; Strong, V. E.; Coit, D. G.; Chou, J. F.; Capanu, M.; Maron, S. B.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Journal of Gastrointestinal Oncology (2023)

    Fulltext@MSK | Save
  • Characterizing the clinico-genomic landscape and outcomes of KRAS G12C mutated pancreas cancer
    Meeting Abstract

    Keane, F.; Park, W.; Varghese, A.; Balogun, F.; Yu, K.; El Dika, I.; Khalil, D.; Kelsen, D. P.; Reidy-Lagunes, D.; Ku, G. Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Clinico-genomic characterization of ATM and HRD in pancreas cancer: Application for practice
    Journal Article

    Park, W.; O'Connor, C. A.; Bandlamudi, C.; Forman, D.; Chou, J. F.; Umeda, S.; Reyngold, M.; Varghese, A. M.; Keane, F.; Balogun, F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
    Journal Article

    Yu, K. H.; Park, J.; Mittal, A.; Abou-Alfa, G. K.; El Dika, I.; Epstein, A. S.; Ilson, D. H.; Kelsen, D. P.; Ku, G. Y.; Li, J.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma
    Journal Article

    Moy, R. H.; Greally, M.; Chou, J. F.; Li, J.; Desai, A. M.; Chalasani, S. B.; Won, E.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; more...
    Cancer Chemotherapy and Pharmacology (2022)

    Fulltext@MSK | Save
  • Early-onset pancreas cancer: Clinical descriptors, genomics, and outcomes
    Journal Article

    Varghese, A. M.; Singh, I.; Singh, R.; Kunte, S.; Chou, J. F.; Capanu, M.; Wong, W.; Lowery, M. A.; Stadler, Z. K.; Salo-Mullen, E.; more...
    JNCI: Journal of the National Cancer Institute (2021)

    Fulltext@MSK | Save